Products
  1. Home
  2. Products
  3. Inhibitors & Activators for IBD Research
Products
Inquiry

* Please note that all of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.

MET kinase-IN-3

Cat. No.: IBDI-434551

MET kinase-IN-3 (compound 8) is an orally active and potent MET inhibitor, with an IC50 of 9.8 nM. MET kinase-IN-3 shows good and broad-spectrum antiproliferative activity against cancer cell lines.

Size (Solid):

Product Details

Target c-Met/HGFR | VEGFR
Molecular Weight 491.88
SMILES NC1=NC=CC(OC2=C(C=C(C=C2)NC3=C4C(C(C5=CC=C(C=C5)F)=CNC4=CC=N3)=O)F)=C1Cl

Storage & Handling

Shipping Room temperature in continental US. May vary elsewhere.
Storage Please store the product under the recommended conditions in the Certificate of Analysis.
Regulatory Status This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use.
! For research use only, not intended for any clinical use.
Copyright © Ace Therapeutics. All rights reserved.